Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Lab-on-a-Chip and Microfluidics: Companies, Technologies and Commercialization

Lidong Qin's Biography



Lidong Qin, Professor and CPRIT Scholar, Houston Methodist Research Institute

Dr. Lidong Qin received his Ph.D. degree from Northwestern University and completed postdoctoral training from California Institute of Technology, in 2007 and 2010 respectively. He moved to Houston Methodist Research Institute in 2010 as an Assistant Professor and was promoted to Associated Professor and Full Professor in 2013 and 2016. He is also a CPRIT scholar awarded by the Cancer Research and Prevention Institute of Texas. His current research interest is in microfluidics biotechnology for translational medicine.

Lidong Qin Image

Microfluidic Biotechnology Enables CRISPR-Cas9 System for Gene Therapy and Cancer Biomarker Discovery

Wednesday, 4 October 2017 at 09:00

Add to Calendar ▼2017-10-04 09:00:002017-10-04 10:00:00Europe/LondonMicrofluidic Biotechnology Enables CRISPR-Cas9 System for Gene Therapy and Cancer Biomarker DiscoverySELECTBIOenquiries@selectbiosciences.com

The CRISPR (clustered regularly interspaced short palindromic repeats)-Cas (CRISPR-associated) nuclease system represents an efficient tool for genome editing and gene function analysis. Integrated microfluidic chips have been well designed with micro and nanostructures to rapidly distinguish cell morphology and dynamics, which are uniquely advantageous in improving efficiency of CRISPR based delivery and screening. Here we combined the two unique technologies to facilitate cancer biomarker discovery and gene therapy.


Add to Calendar ▼2017-10-02 00:00:002017-10-04 00:00:00Europe/LondonLab-on-a-Chip and Microfluidics: Companies, Technologies and CommercializationSELECTBIOenquiries@selectbiosciences.com